Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals

被引:36
作者
Bajnok, Laszlo [1 ]
Seres, Ildiko
Varga, Zsuzsa
Jeges, Sara
Peti, Attila
Karanyi, Zsolt
Juhasz, Attila
Csongradi, Eva
Mezosi, Emese
Nagy, Endre V.
Paragh, Gyorgy
机构
[1] Univ Pecs, Sch Med, Dept Med 1, H-7624 Pecs, Hungary
[2] Univ Debrecen, Med & Hlth Sci Ctr, Dept Med 1, H-4012 Debrecen, Hungary
[3] Univ Pecs, Fac Hlth Sci, Inst Bioanal, Sch Med & Applied Hlth Sci, H-7624 Pecs, Hungary
[4] Univ Pecs, Fac Med, Inst Lab Med, H-7624 Pecs, Hungary
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2007年 / 56卷 / 11期
关键词
D O I
10.1016/j.metabol.2007.06.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Altered activities of high-density lipoprotein (HDL)-associated antioxiclant enzyme paraoxonase I (PON1) and lipid transfer proteins, for example, cholesteryl ester transfer protein (CETP) and lecithin cholesterol acyltransferase (LCAT), participating in lipoprotein remodeling seem to play important roles in obesity-related accelerated atherosclerosis. Inverse associations of PON1 with obesity and serum leptin levels have been demonstrated. However, the relationship of leptin with CETP and LCAT in humans is less clear. Our aims were to investigate whether the elevated leptin level is (a) an independent predictor of low PON1 and (b) associated with alterations of CETP and LCAT activities. Seventv-four white subjects forming 3 age- and sex-matched groups were included into the study (groups I and 2: nondiabetic obese patients, n = 25 with body mass index [BMI] 28-39.9 kg/m(2) and n = 25 with BMI >= 40 kg/m(2), 9 respectively; and group 3: 24 healthy, normal-weiaht control subjects). Paraoxonase I correlated inversely with BMI (r = -0.39, P <.01), waist circumferences (r = -0.42, P <.001), and leptin concentrations (r = -0.38, P <.001). However, in a multiple regression model, neither these variables nor others, for example, age, sex, blood pressure, insulin resistance (in homeostasis model assessment of insulin resistance [HOMA-IR]), HDL cholesterol, low-density lipoprotein cholesterol, or lipid peroxidation (measured as thiobarbituric acid reactive substances), proved to be independent predictors of PON1. Lecithin cholesterol acyltransferase correlated negatively with BMI (r = -0.40, P<.01), waist circumferences (r= -0.42, P <.001), and leptin levels (r = -0.40, P <.01). During multiple regression analyses, BMI was an independent predictor of LCAT after adjustments for age, sex, HOMA-IR, and HDL cholesterol. However, this was replaced by leptin and HOMA-IR when leptin was also included into the model. The CETP activities con-elated with HOMA-IR (r = 0.33, P <.01), thiobarbituric acid reactive substances (r = 0.45, P <.00 1), and leptin (r = 0.36 P <.01) levels in univariate but not in inultivariate models. Elevated leptin level is an independent predictor of low LCAT, but not PON1, activity. In a population with a wide range of BMI, LCAT correlates inversely with obesity and CETP directly with insulin resistance. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1542 / 1549
页数:8
相关论文
共 29 条
[1]   SERUM PARAOXONASE ACTIVITY, CONCENTRATION, AND PHENOTYPE DISTRIBUTION IN DIABETES-MELLITUS AND ITS RELATIONSHIP TO SERUM-LIPIDS AND LIPOPROTEINS [J].
ABBOTT, CA ;
MACKNESS, MI ;
KUMAR, S ;
BOULTON, AJ ;
DURRINGTON, PN .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (11) :1812-1818
[2]   GLYCEMIA AND BODY-MASS AS DETERMINANTS OF PLASMA LECITHIN - CHOLESTEROL ACYLTRANSFERASE ACTIVITY IN NIGERIAN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
AKANJI, AO ;
AGBEDANA, EO .
CLINICA CHIMICA ACTA, 1995, 238 (01) :35-42
[3]   INCREASED PLASMA CHOLESTERYL ESTER TRANSFER PROTEIN IN OBESE SUBJECTS - A POSSIBLE MECHANISM FOR THE REDUCTION OF SERUM HDL CHOLESTEROL LEVELS IN OBESITY [J].
ARAI, T ;
YAMASHITA, S ;
HIRANO, KI ;
SAKAI, N ;
KOTANI, K ;
FUJIOKA, S ;
NOZAKI, S ;
KENO, Y ;
YAMANE, M ;
SHINOHARA, E ;
ISLAM, AHMW ;
ISHIGAMI, M ;
NAKAMURA, T ;
KAMEDATAKEMURA, K ;
TOKUNAGA, K ;
MATSUZAWA, Y .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (07) :1129-1136
[4]   Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants [J].
Aviram, M ;
Rosenblat, M ;
Billecke, S ;
Erogul, J ;
Sorenson, R ;
Bisgaier, CL ;
Newton, RS ;
La Du, B .
FREE RADICAL BIOLOGY AND MEDICINE, 1999, 26 (7-8) :892-904
[5]   Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia [J].
Beltowski, J ;
Wojcicka, G ;
Jamroz, A .
ATHEROSCLEROSIS, 2003, 170 (01) :21-29
[6]   The effect of cholesteryl ester transfer protein-629C→A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides [J].
Borggreve, SE ;
Hillege, HL ;
Wolffenbuttel, BHR ;
de Jong, PE ;
Bakker, SJL ;
van der Steege, G ;
van Tol, A ;
Dullaart, RPF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (07) :4198-4204
[7]   Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin : cholesterol acyltransferase and lipid transfer proteins [J].
Borggreve, SE ;
de Vries, R ;
Dullaart, RPF .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 (12) :1051-1069
[8]   Lipoprotein transport in the metabolic syndrome: pathophysiological and interventional studies employing stable isotopy and modelling methods [J].
Chan, DC ;
Barrett, PHR ;
Watts, GF .
CLINICAL SCIENCE, 2004, 107 (03) :233-249
[9]   Leptinemia is not a risk factor for ischemic heart disease in men -: Prospective results from the Quebec Cardiovascular Study [J].
Couillard, C ;
Lamarche, B ;
Mauriège, P ;
Cantin, B ;
Dagenais, GR ;
Moorjani, S ;
Lupien, PJ ;
Després, JP .
DIABETES CARE, 1998, 21 (05) :782-786
[10]   EFFECT OF ADIPOSITY ON PLASMA-LIPID TRANSFER PROTEIN ACTIVITIES - A POSSIBLE LINK BETWEEN INSULIN-RESISTANCE AND HIGH-DENSITY-LIPOPROTEIN METABOLISM [J].
DULLAART, RPF ;
SLUITER, WJ ;
DIKKESCHEI, LD ;
HOOGENBERG, K ;
VANTOL, A .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (03) :188-194